Importantly, aberrant BET activity, particularly that of BRD4, has been linked to the overexpression of oncogenes such as MYC, BCL-2, and NF-κB, which drive tumor proliferation, survival, and immune evasion [146, 147]. Here, BRD4 is linked to neoplasm.